Health-related Quality of Life in Patients on Anticoagulants
NCT ID: NCT03134911
Last Updated: 2019-04-18
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
535 participants
OBSERVATIONAL
2017-04-24
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
IRAF-ABLATION Study: a Multicenter International Retrospective Cohort of Patients With BTK Inhibitors-related AF Treated by Catheter Ablation
NCT06130709
Application of "I-Anticoagulation"in Patients With Atrial Fibrillation
NCT06137794
Triggers and Risk Factors for Recurrence of Atrial Arrhythmias With the Use of Long-term Monitoring
NCT05526170
Spanish Atrial Fibrillation And Resynchronization Study
NCT01181414
Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study)
NCT02447341
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
anticoagulation controlled patients
Treated with DOAC or VKA
DOAC or VKA
6 months - 2 years
anticoagulation non controlled patients
Treated with VKA
VKA
6 months - 2 years
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DOAC or VKA
6 months - 2 years
VKA
6 months - 2 years
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient is at least 18 years of age
* The patient has a diagnosis of non-valvular atrial fibrillation
* The patient is on the same anticoagulant therapy (VKA or DOAC) during at least 6 months and maximum 2 years.
* If treated with VKA, availability of % Time in Therapeutic Range (TTR) in past analytical records or enough amount of International Normalized Ratio (INR) measures to calculate it.
Exclusion Criteria
* Contraindication to the use of DOAC or VKA as described in the Summary of Product Characteristics (SmPC).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boehringer Ingelheim
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitario Príncipe de Asturias
Alcalá de Henares (Madrid), , Spain
HospitalUniversitario Príncipe de Asturias
Alcalá de Henares (Madrid), , Spain
Hospita Universitario Fundación Alcorcón
Alcorcón (Madrid), , Spain
Hospital Público Virgen de los Lirios
Alcoy (Alicante), , Spain
Hospital General Universitario de Alicante
Alicante, , Spain
Hospital Universitario San Juan de Alicante
Alicante, , Spain
Complejo Hospitalario Torrecárdenas
Almería, , Spain
Hospital Universitario Monteprincipe
Boadilla Del Monte (Madrid), , Spain
Hospital San Juan de Dios
Bormujos (Sevilla), , Spain
Hospital General Universitario de Castellón
Castellón de La Plana (Castellón), , Spain
Hospital Universitario Reina Sofía
Córdoba, , Spain
Hospital General Universitario de Elche
Elche (Alicante), , Spain
Hospital Universitario de Fuenlabrada
Fuenlabrada (Madrid), , Spain
Hospital Comarcal Francesc de Borja
Gandía (València), , Spain
Hospital Universitario Virgen de las Nieves
Granada, , Spain
Hospital Universitari Arnau de Vilanova
Lleida, , Spain
Hospital De Llíria (depende del Arnau de Vilanova)
Llíria (Valencia), , Spain
Hospital de La Princesa
Madrid, , Spain
Hospital General Universitario Gregorio Marañon
Madrid, , Spain
Hopital Clinico San Carlos
Madrid, , Spain
Hospital Universitario Fundación Jiménez Díaz
Madrid, , Spain
Hospital Universitario Doce de Octubre
Madrid, , Spain
Hospital Universitario Puerta de Hierro
Majadahonda (Madrid), , Spain
Hospital Costa del Sol
Marbella (Málaga), , Spain
Complejo Hospitalario de Especialidades Virgen de la Victoria
Málaga, , Spain
Hospital Regional de Málaga (Carlos Haya)
Málaga, , Spain
Hospital Universitario Rey Juan Carlos
Móstoles (Madrid), , Spain
Hospital Universitario de Móstoles
Móstoles (Madrid), , Spain
Hospital Vega Baja
Orihuela (Alicante), , Spain
Hospital Virgen del Camino
Pamplona (Navarra), , Spain
Hospital General de Requena
Requena (Valencia), , Spain
Hospital de Sagunto
Sagunto (Valencia), , Spain
Hospital Universitario Infanta Sofia
San Sebastián de Los Reyes (Madrid), , Spain
Hospital Universitario Virgen Macarena
Seville, , Spain
Hospital Universitario de Torrevieja
Torrrevieja (Alicante), , Spain
Hospital Clínico Universitariio de Valencia
Valencia, , Spain
Consorcio Hospital General Universitario de Valencia
Valencia, , Spain
Hospital Universitario de La Plana
Villarreal (Castellón), , Spain
Hospital Lluis Alcanyis
Xàtiva (Valencia), , Spain
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1160-0280
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.